Verapamil for treatment of Fetal Supraventricular Tachycardia

Authors

  • Amit Kumar Singh Shahid Gangalal National Heart Centre, Janakpur Branch, Janakpurdham, Nepal https://orcid.org/0000-0003-4496-0436
  • Murari Thakur Department of Gynaecology, Provincial Hospital, Madhesh Province, Nepal
  • Ruby Singh Department of Gynaecology, Provincial Hospital, Madhesh Province, Nepal
  • Jitendra Mandal Department of Radiology, Provincial Hospital, Madhesh Province, Nepal

DOI:

https://doi.org/10.3126/njh.v20i1.55042

Keywords:

Verapamil, Fetal supraventricular tachycardia

Abstract

Fetal arrythmia is reported to affect 1-2% of pregnancies. Besides digoxin not many drugs have been tried in treating such cases. After confirming 1:1 conduction between atrium and ventricle, no structural heart disease of fetus and normal echocardiography and ECG of mother, verapamil was given in the treatment of fetal supraventricular tachycardia. The drug crossed placenta to revert fetus SVT to sinus rhythm without harming mother. The treatment helped fetus against possible complications.

Downloads

Download data is not yet available.
Abstract
64
PDF
144

Downloads

Published

2023-06-10

How to Cite

Singh, A. K., Thakur, M., Singh, R., & Mandal, J. (2023). Verapamil for treatment of Fetal Supraventricular Tachycardia. Nepalese Heart Journal, 20(1), 57–59. https://doi.org/10.3126/njh.v20i1.55042

Issue

Vol. 20 No. 1 (2023)

Section

Case Reports

License

Copyright (c) 2023 Nepalese Heart Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.